User:Ryan Walsh: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 28: Line 28:
<!-- Replace the PubMed ID's ("pmid=#######") below with the PubMed ID's for your publications.  You can add or remove lines as needed -->
<!-- Replace the PubMed ID's ("pmid=#######") below with the PubMed ID's for your publications.  You can add or remove lines as needed -->
<biblio>
<biblio>
#Paper1 pmid=6947258
# Walsh R, Martin E, Darvesh S. Limitations of conventional inhibitor classifications. Integr Biol (Camb). 2011 Oct 31. [Epub ahead of print] pmid=22038120
#Paper2 pmid=13718526
#Walsh R, Rockwood K, Martin E, Darvesh S. Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram. Biochim Biophys Acta. 2011 Aug 19;1810(12):1230-1235. pmid=21872646
 
#Shevchenko Y, Francis TJ, Blair DA, Walsh R, DeRosa MC, Albert J. In situ biosensing with a surface plasmon resonance fiber grating aptasensor. Anal Chem. 2011 Sep 15;83(18):7027-34. pmid=21815621
1. Walsh R, Martin E, Darvesh S. Limitations of conventional inhibitor classifications. Integr Biol (Camb). 2011 Oct 31. [Epub ahead of print]
#Holahan MR, Madularu D, McConnell EM, Walsh R, DeRosa MC. Intra-accumbens injection of a dopamine aptamer abates MK-801-induced cognitive dysfunction in a model of schizophrenia. PLoS One. 2011;6(7):e22239. pmid=21779401
 
#Rockwood K, Walsh R, Martin E, Darvesh S. Potentially procholinergic effects of medications commonly used in older adults. Am J Geriatr Pharmacother. 2011 Feb;9(1):80-7. pmid=21459311
2. Walsh R, Rockwood K, Martin E, Darvesh S. Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram. Biochim Biophys Acta. 2011 Aug 19;1810(12):1230-1235.  
#Darvesh S, Pottie IR, Darvesh KV, McDonald RS, Walsh R, Conrad S, Penwell A, Mataija D, Martin E. Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants. Bioorg Med Chem. 2010 Mar 15;18(6):2232-44. pmid=20181484
 
#DeRosa MC, Monreal C, Schnitzer M, Walsh R, Sultan Y. Nanotechnology in fertilizers. Nat Nanotechnol. 2010 Feb;5(2):91. pmid=20130583
3. Shevchenko Y, Francis TJ, Blair DA, Walsh R, DeRosa MC, Albert J. In situ biosensing with a surface plasmon resonance fiber grating aptasensor. Anal Chem. 2011 Sep 15;83(18):7027-34.
#Walsh R, Martin E, Darvesh S. A method to describe enzyme-catalyzed reactions by combining steady state and time course enzyme kinetic parameters. Biochim Biophys Acta. 2010 Jan;1800(1):1-5. pmid=19840832
 
#Walsh R, DeRosa MC. Retention of function in the DNA homolog of the RNA dopamine aptamer. Biochem Biophys Res Commun. 2009 Oct 30;388(4):732-5. pmid=19699181
4. Holahan MR, Madularu D, McConnell EM, Walsh R, DeRosa MC. Intra-accumbens injection of a dopamine aptamer abates MK-801-induced cognitive dysfunction in a model of schizophrenia. PLoS One. 2011;6(7):e22239.  
#Sultan Y, Walsh R, Monreal C, DeRosa MC. Preparation of functional aptamer films using layer-by-layer self-assembly. Biomacromolecules. 2009 May 11;10(5):1149-54. pmid=19385646
 
#Darvesh S, Darvesh KV, McDonald RS, Mataija D, Walsh R, Mothana S, Lockridge O, Martin E. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase. J Med Chem. 2008 Jul 24;51(14):4200-12. pmid=18570368
5. Rockwood K, Walsh R, Martin E, Darvesh S. Potentially procholinergic effects of medications commonly used in older adults. Am J Geriatr Pharmacother. 2011 Feb;9(1):80-7.
#Darvesh S, McDonald RS, Darvesh KV, Mataija D, Conrad S, Gomez G, Walsh R, Martin E. Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorg Med Chem. 2007 Oct 1;15(19):6367-78. pmid=17681768
 
#Walsh R, Martin E, Darvesh S. A versatile equation to describe reversible enzyme inhibition and activation kinetics: modeling beta-galactosidase and butyrylcholinesterase. Biochim Biophys Acta. 2007 May;1770(5):733-46. pmid=17307293
6. Darvesh S, Pottie IR, Darvesh KV, McDonald RS, Walsh R, Conrad S, Penwell A, Mataija D, Martin E. Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants. Bioorg Med Chem. 2010 Mar 15;18(6):2232-44.
#Darvesh S, Walsh R, Martin E. Homocysteine thiolactone and human cholinesterases. Cell Mol Neurobiol. 2007 Feb;27(1):33-48. pmid=16955366
 
#Darvesh S, McDonald RS, Darvesh KV, Mataija D, Mothana S, Cook H, Carneiro KM, Richard N, Walsh R, Martin E. On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases. Bioorg Med Chem. 2006 Jul 1;14(13):4586-99. pmid=16504521
7. DeRosa MC, Monreal C, Schnitzer M, Walsh R, Sultan Y. Nanotechnology in fertilizers. Nat Nanotechnol. 2010 Feb;5(2):91.  
#Darvesh S, McDonald RS, Penwell A, Conrad S, Darvesh KV, Mataija D, Gomez G, Caines A, Walsh R, Martin E. Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives. Bioorg Med Chem. 2005 Jan 3;13(1):211-22. pmid=15582466
 
#Darvesh S, Martin E, Walsh R, Rockwood K. Differential effects of lipid-lowering agents on human cholinesterases. Clin Biochem. 2004 Jan;37(1):42-9. pmid=14675561
8. Walsh R, Martin E, Darvesh S. A method to describe enzyme-catalyzed reactions by combining steady state and time course enzyme kinetic parameters. Biochim Biophys Acta. 2010 Jan;1800(1):1-5.  
#Darvesh S, Walsh R, Kumar R, Caines A, Roberts S, Magee D, Rockwood K, Martin E Inhibition of human cholinesterases by drugs used to treat Alzheimer disease. Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):117-26. pmid=12794390
 
#Darvesh S, Walsh R, Martin E. Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases. Cell Mol Neurobiol. 2003 Feb;23(1):93-100. pmid=12701885
9. Walsh R, DeRosa MC. Retention of function in the DNA homolog of the RNA dopamine aptamer. Biochem Biophys Res Commun. 2009 Oct 30;388(4):732-5.  
#Darvesh S, Kumar R, Roberts S, Walsh R, Martin E. Butyrylcholinesterase-Mediated enhancement of the enzymatic activity of trypsin. Cell Mol Neurobiol. 2001 Jun;21(3):285-96. pmid=11569538
 
10. Sultan Y, Walsh R, Monreal C, DeRosa MC. Preparation of functional aptamer films using layer-by-layer self-assembly. Biomacromolecules. 2009 May 11;10(5):1149-54.
 
11. Darvesh S, Darvesh KV, McDonald RS, Mataija D, Walsh R, Mothana S, Lockridge O, Martin E. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase. J Med Chem. 2008 Jul 24;51(14):4200-12.  
 
12. Darvesh S, McDonald RS, Darvesh KV, Mataija D, Conrad S, Gomez G, Walsh R, Martin E. Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorg Med Chem. 2007 Oct 1;15(19):6367-78.
 
13. Walsh R, Martin E, Darvesh S. A versatile equation to describe reversible enzyme inhibition and activation kinetics: modeling beta-galactosidase and butyrylcholinesterase. Biochim Biophys Acta. 2007 May;1770(5):733-46.  
 
14. Darvesh S, Walsh R, Martin E. Homocysteine thiolactone and human cholinesterases. Cell Mol Neurobiol. 2007 Feb;27(1):33-48.  
 
15. Darvesh S, McDonald RS, Darvesh KV, Mataija D, Mothana S, Cook H, Carneiro KM, Richard N, Walsh R, Martin E. On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases. Bioorg Med Chem. 2006 Jul 1;14(13):4586-99.  
 
16. Darvesh S, McDonald RS, Penwell A, Conrad S, Darvesh KV, Mataija D, Gomez G, Caines A, Walsh R, Martin E. Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives. Bioorg Med Chem. 2005 Jan 3;13(1):211-22.
 
17. Darvesh S, Martin E, Walsh R, Rockwood K. Differential effects of lipid-lowering agents on human cholinesterases. Clin Biochem. 2004 Jan;37(1):42-9.
 
18. Darvesh S, Walsh R, Kumar R, Caines A, Roberts S, Magee D, Rockwood K, Martin E Inhibition of human cholinesterases by drugs used to treat Alzheimer disease. Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):117-26.
 
19. Darvesh S, Walsh R, Martin E. Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases. Cell Mol Neurobiol. 2003 Feb;23(1):93-100.
 
20. Darvesh S, Kumar R, Roberts S, Walsh R, Martin E. Butyrylcholinesterase-Mediated enhancement of the enzymatic activity of trypsin. Cell Mol Neurobiol. 2001 Jun;21(3):285-96.




Revision as of 11:09, 8 November 2011

I am a new member of OpenWetWare!

Contact Info

Ryan Walsh (an artistic interpretation)

I work in the Your Lab at XYZ University. I learned about OpenWetWare from nature biobrick article a few years ago I believe, and I've joined because My supervisor has started a lab page.

Education

  • Year, PhD, Institute
  • Year, MS, Institute
  • Year, BS, Institute

Research interests

  1. Interest 1
  2. Interest 2
  3. Interest 3

Publications

  1. R, DeRosa MC. Retention of function in the DNA homolog of the RNA dopamine aptamer. Biochem Biophys Res Commun. 2009 Oct 30;388(4):732-5. pmid=19699181

    [Walsh]

  2. R, Martin E, Darvesh S. A method to describe enzyme-catalyzed reactions by combining steady state and time course enzyme kinetic parameters. Biochim Biophys Acta. 2010 Jan;1800(1):1-5. pmid=19840832

    [Walsh]

  3. R, Martin E, Darvesh S. A versatile equation to describe reversible enzyme inhibition and activation kinetics: modeling beta-galactosidase and butyrylcholinesterase. Biochim Biophys Acta. 2007 May;1770(5):733-46. pmid=17307293

    [Walsh]

  4. R, Martin E, Darvesh S. Limitations of conventional inhibitor classifications. Integr Biol (Camb). 2011 Oct 31. [Epub ahead of print] pmid=22038120

    [Walsh]

  5. R, Rockwood K, Martin E, Darvesh S. Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram. Biochim Biophys Acta. 2011 Aug 19;1810(12):1230-1235. pmid=21872646

    [Walsh]

  6. Y, Francis TJ, Blair DA, Walsh R, DeRosa MC, Albert J. In situ biosensing with a surface plasmon resonance fiber grating aptasensor. Anal Chem. 2011 Sep 15;83(18):7027-34. pmid=21815621

    [Shevchenko]

  7. MR, Madularu D, McConnell EM, Walsh R, DeRosa MC. Intra-accumbens injection of a dopamine aptamer abates MK-801-induced cognitive dysfunction in a model of schizophrenia. PLoS One. 2011;6(7):e22239. pmid=21779401

    [Holahan]

  8. K, Walsh R, Martin E, Darvesh S. Potentially procholinergic effects of medications commonly used in older adults. Am J Geriatr Pharmacother. 2011 Feb;9(1):80-7. pmid=21459311

    [Rockwood]

  9. S, Darvesh KV, McDonald RS, Mataija D, Walsh R, Mothana S, Lockridge O, Martin E. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase. J Med Chem. 2008 Jul 24;51(14):4200-12. pmid=18570368

    [Darvesh]

  10. S, Kumar R, Roberts S, Walsh R, Martin E. Butyrylcholinesterase-Mediated enhancement of the enzymatic activity of trypsin. Cell Mol Neurobiol. 2001 Jun;21(3):285-96. pmid=11569538

    [Darvesh]

    leave a comment about a paper here

  11. S, Martin E, Walsh R, Rockwood K. Differential effects of lipid-lowering agents on human cholinesterases. Clin Biochem. 2004 Jan;37(1):42-9. pmid=14675561

    [Darvesh]

  12. S, McDonald RS, Darvesh KV, Mataija D, Conrad S, Gomez G, Walsh R, Martin E. Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorg Med Chem. 2007 Oct 1;15(19):6367-78. pmid=17681768

    [Darvesh]

  13. S, McDonald RS, Darvesh KV, Mataija D, Mothana S, Cook H, Carneiro KM, Richard N, Walsh R, Martin E. On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases. Bioorg Med Chem. 2006 Jul 1;14(13):4586-99. pmid=16504521

    [Darvesh]

  14. S, McDonald RS, Penwell A, Conrad S, Darvesh KV, Mataija D, Gomez G, Caines A, Walsh R, Martin E. Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives. Bioorg Med Chem. 2005 Jan 3;13(1):211-22. pmid=15582466

    [Darvesh]

  15. S, Pottie IR, Darvesh KV, McDonald RS, Walsh R, Conrad S, Penwell A, Mataija D, Martin E. Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants. Bioorg Med Chem. 2010 Mar 15;18(6):2232-44. pmid=20181484

    [Darvesh]

  16. S, Walsh R, Kumar R, Caines A, Roberts S, Magee D, Rockwood K, Martin E Inhibition of human cholinesterases by drugs used to treat Alzheimer disease. Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):117-26. pmid=12794390

    [Darvesh]

  17. S, Walsh R, Martin E. Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases. Cell Mol Neurobiol. 2003 Feb;23(1):93-100. pmid=12701885

    [Darvesh]

  18. S, Walsh R, Martin E. Homocysteine thiolactone and human cholinesterases. Cell Mol Neurobiol. 2007 Feb;27(1):33-48. pmid=16955366

    [Darvesh]

  19. MC, Monreal C, Schnitzer M, Walsh R, Sultan Y. Nanotechnology in fertilizers. Nat Nanotechnol. 2010 Feb;5(2):91. pmid=20130583

    [DeRosa]

  20. Y, Walsh R, Monreal C, DeRosa MC. Preparation of functional aptamer films using layer-by-layer self-assembly. Biomacromolecules. 2009 May 11;10(5):1149-54. pmid=19385646

    [Sultan]
  21. ISBN:0879697164 [Book1]

Useful links

Retrieved from "https://openwetware.org/mediawiki/index.php?title=User:Ryan_Walsh&oldid=565217"